BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 31, 2012
View Archived Issues
Isis Innovation presents new dsNA molecules for Parkinson's disease
Read More
Del Mar Pharmaceuticals expands collaboration with Guangxi Wuzhou Pharmaceutical
Read More
Global phase III trial of ART-123 commences
Read More
AstraZeneca begins new global study of Faslodex
Read More
Astex Pharmaceuticals, CRT and Newcastle University form drug discovery alliance
Read More
Chinese researchers disclose novel Lp-PLA2 inhibitors
Read More
Astellas Pharma prepares new PDE10A inhibitors
Read More
New modulators of the expression of aquaporin-3 patented by Lipotec
Read More
Dainippon Sumitomo Pharma synthesizes novel nACh alpha7 receptor modulators
Read More
Researchers at Pathway Therapeutics disclose new PI3K inhibitors
Read More
Complix receives government grant for Alphabodies development
Read More
Takeda submits Japanese NDA for cetilistat
Read More
Astellas Pharma launches Quattrovac vaccine in Japan
Read More
Combination of BKM-120 and irinotecan evaluated in phase I trial
Read More
TransTech Pharma's TTP-488 slows cognitive decline in Alzheimer's disease
Read More
Preliminary phase II data presented for lubrinectedin in ovarian cancer
Read More
Cytokinetics begins phase IIb BENEFIT-ALS trial
Read More
Amgen offers overview of third quarter 2012 results
Read More
Novartis reports third quarter results for 2012
Read More
European Commission approves Cialis in new indication
Read More
FDA accepts two Latuda supplemental NDAs for review
Read More
Oral salmon calcitonin shows potential as antidiabetic therapy in vivo
Read More
GSK begins phase III program for mepolizumab in severe refractory asthma
Read More
Phase I IPH-2102 trial begins patient recruitment
Read More
NCI presents phase II data for a cervical cancer vaccine
Read More
Semaphorin-3A demonstrates osteoprotective qualities and therapeutic potential
Read More